Literature DB >> 20442528

Bortezomib-induced acute pancreatitis.

Bouraoui Elouni, Chaker Ben Salem, Michelle Zamy, Jaballah Sakhri, Kamel Bouraoui, Michel Biour.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20442528

Source DB:  PubMed          Journal:  JOP        ISSN： 1590-8577


× No keyword cloud information.
  6 in total

Review 1.  Drug-induced pancreatitis.

Authors:  Claudia Nitsche; Sandrina Maertin; Jonas Scheiber; Christoph A Ritter; Markus M Lerch; Julia Mayerle
Journal:  Curr Gastroenterol Rep       Date:  2012-04

2.  Phase 1 study of sorafenib in combination with bortezomib in patients with advanced malignancies.

Authors:  Shaji K Kumar; James Jett; Randolph Marks; Ronald Richardson; Fernando Quevedo; Timothy Moynihan; Gary Croghan; Svetomir N Markovic; Keith C Bible; Rui Qin; Angelina Tan; Julian Molina; Scott H Kaufmann; Charles Erlichman; Alex A Adjei
Journal:  Invest New Drugs       Date:  2013-07-26       Impact factor: 3.850

3.  New indication for therapeutic potential of an old well-known drug (propranolol) for multiple myeloma.

Authors:  Ilknur Kozanoglu; Melis Kartal Yandim; Zeynep Birsu Cincin; Hakan Ozdogu; Bedia Cakmakoglu; Yusuf Baran
Journal:  J Cancer Res Clin Oncol       Date:  2012-10-19       Impact factor: 4.553

4.  Chemotherapy-induced fulminant acute pancreatitis in pancreatic carcinoma: A case report.

Authors:  Linghui Lu; Yanni Lou; Huangying Tan
Journal:  Oncol Lett       Date:  2014-07-04       Impact factor: 2.967

5.  An unusual complication of bortezomib therapy: Acute pancreatitis.

Authors:  H Gupta; R Bansal; S Khanna; S Saxena
Journal:  Indian J Nephrol       Date:  2014-03

6.  Management of pancreatitis related to Bortezomib treatment: report of two cases.

Authors:  Erika Brulc; Cristian Seehaus; Natalia Schutz; Dorotea Fantl
Journal:  Hematol Transfus Cell Ther       Date:  2018-05-19
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.